Live feed03:00:00·1522dPRReleasevia QuantisnowVertex and CRISPR Therapeutics Present New Data on More Patients With Longer Follow-Up Treated With exagamglogene autotemcel (exa-cel) at the 2022 European Hematology Association (EHA) CongressByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGVRTX· Vertex Pharmaceuticals IncorporatedHealth Care
